- Home
- UEC vs IRON Comparison
UEC vs IRON Comparison
Compare UEC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEC
- IRON
- Stock Information
- Founded
- UEC 2003
- IRON 2017
- Country
- UEC United States
- IRON United States
- Employees
- UEC N/A
- IRON N/A
- Industry
- UEC Other Metals and Minerals
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- UEC Basic Materials
- IRON Health Care
- Exchange
- UEC Nasdaq
- IRON Nasdaq
- Market Cap
- UEC 2.0B
- IRON 1.9B
- IPO Year
- UEC N/A
- IRON N/A
- Fundamental
- Price
- UEC $5.05
- IRON $42.17
- Analyst Decision
- UEC Strong Buy
- IRON Strong Buy
- Analyst Count
- UEC 2
- IRON 10
- Target Price
- UEC $11.25
- IRON $83.80
- AVG Volume (30 Days)
- UEC 9.5M
- IRON 608.5K
- Earning Date
- UEC 06-09-2025
- IRON 05-08-2025
- Dividend Yield
- UEC N/A
- IRON N/A
- EPS Growth
- UEC N/A
- IRON N/A
- EPS
- UEC N/A
- IRON N/A
- Revenue
- UEC $66,837,000.00
- IRON N/A
- Revenue This Year
- UEC $60,962.50
- IRON N/A
- Revenue Next Year
- UEC $34.61
- IRON N/A
- P/E Ratio
- UEC N/A
- IRON N/A
- Revenue Growth
- UEC 12.54
- IRON N/A
- 52 Week Low
- UEC $3.85
- IRON $25.64
- 52 Week High
- UEC $8.93
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- UEC 53.06
- IRON 42.98
- Support Level
- UEC $4.56
- IRON $39.20
- Resistance Level
- UEC $5.13
- IRON $41.41
- Average True Range (ATR)
- UEC 0.38
- IRON 4.37
- MACD
- UEC 0.09
- IRON 0.09
- Stochastic Oscillator
- UEC 93.75
- IRON 54.14
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.